Skip to main content
Log in

A novel missense mutation in the antithrombin III gene (Ala387→Val) causing recurrent venous thrombosis

  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

A novel GCT→GTT transition in the antithrombin III (ATIII) gene, resulting in an Ala387→Val substitution near the reactive site, was detected in a patient with recurrent venous thrombosis and ATIII activity/antigen levels consistent with type I ATIII deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barrowcliffe TW, Thomas DP (1987) Antithrombin III and heparin. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis, 2nd edn. Churchill Livingstone, Edinburgh, pp 849–869

    Google Scholar 

  • Beresford CH (1988) Antithrombin III deficiency. Blood Rev 2:239–250

    Google Scholar 

  • Bock SC, Harris JF, Balazs I, Trent JM (1985) Assigment of the human antithrombin III structural gene to chromosome 1q23–25. Cytogenet Cell Genet 39:67–69

    Google Scholar 

  • Bock SC, Marrinan JA, Radziejewska E (1988) Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site. Biochemistry 27:6171–6178

    Google Scholar 

  • Cooper DN (1991) The molecular genetics of familial venous thrombosis. Blood Rev 5:55–70

    Google Scholar 

  • Cosgriff TM, Bishop DT, Hershgold EJ, Skolnick MH, Martin BA, Baty BJ, Carlson KS (1983) Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine 62:209–220

    Google Scholar 

  • Gladson CL, Sharrer I, Hach V, Beck KH, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients and venous thrombosis. Thromb Haemost 59:18–22

    Google Scholar 

  • Grundy CB, Thomas F, Millar DS, Krawczak M, Melissari E, Lindo V, Moffat E, Kakkar VV, Cooper DN (1991) Recurrent deletion in the human antithrombin III gene. Blood 78:1027–1032

    Google Scholar 

  • Lane DA, Ireland H, Olds RJ, Thein SL, Perry DJ, Aiach M (1991) Antithrombin III: a database of mutations. Thromb Haemost 66:657–661

    Google Scholar 

  • Prochownik EV, Bock SC, Orkin SH (1985) Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily. J Biol Chem 260:9608–9612

    Google Scholar 

  • Scully MF (1983) The use of an automated analyzer in the evaluation of antithrombin III and heparin. Semin Thromb Haemost 9:309–313

    Google Scholar 

  • Stein PE, Leslie AGW, Finch JT, Turnell WG, McLaughlin PJ, Carrell RW (1990) Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 347:99–102

    Google Scholar 

  • Ye RD, Wun T-C, Sadler JE (1987) cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J Biol Chem 262:3718–3725

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

White, D., Abraham, G., Carter, C. et al. A novel missense mutation in the antithrombin III gene (Ala387→Val) causing recurrent venous thrombosis. Hum Genet 90, 472–473 (1992). https://doi.org/10.1007/BF00220482

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00220482

Keywords

Navigation